DK0587047T3 - Farmaceutisk præparat på gestagenbasis - Google Patents
Farmaceutisk præparat på gestagenbasisInfo
- Publication number
- DK0587047T3 DK0587047T3 DK93114056T DK93114056T DK0587047T3 DK 0587047 T3 DK0587047 T3 DK 0587047T3 DK 93114056 T DK93114056 T DK 93114056T DK 93114056 T DK93114056 T DK 93114056T DK 0587047 T3 DK0587047 T3 DK 0587047T3
- Authority
- DK
- Denmark
- Prior art keywords
- progestagen
- basis
- pharmaceutical preparation
- pharmaceutical
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4229820A DE4229820C2 (de) | 1992-09-07 | 1992-09-07 | Pharmazeutische Zubereitung auf Gestagen-Basis |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0587047T3 true DK0587047T3 (da) | 2002-04-08 |
Family
ID=6467385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93114056T DK0587047T3 (da) | 1992-09-07 | 1993-09-02 | Farmaceutisk præparat på gestagenbasis |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0587047B1 (da) |
DE (2) | DE4229820C2 (da) |
DK (1) | DK0587047T3 (da) |
ES (1) | ES2169722T3 (da) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4405899A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Mittel zur transdermalen Applikation enthaltend Desogestrel |
AU3723695A (en) * | 1994-09-14 | 1996-03-29 | Minnesota Mining And Manufacturing Company | Transdermal device for delivery of levonorgestrel |
PL181406B1 (pl) * | 1994-09-22 | 2001-07-31 | Akzo Nobel Nv | Sposób wytwarzania postaci uzytkowych srodka farmaceutycznego zawierajacego co najmniej jeden progestogen i tabletka zawierajaca progestogen PL PL PL PL PL |
DE19534209A1 (de) * | 1995-09-15 | 1997-03-20 | Jenapharm Gmbh | Hormonales Mittel zur Behandlung der Haut |
FR2739559B1 (fr) * | 1995-10-05 | 1997-11-28 | Innothera Lab Sa | Gel pour hormonotherapie locale de la secheresse vaginale |
DE19701949A1 (de) * | 1997-01-13 | 1998-07-16 | Jenapharm Gmbh | Transdermales therapeutisches System |
FR2766710B1 (fr) * | 1997-08-04 | 1999-10-29 | Inst Pharma De Rech Applic Et | Composition pharmaceutique, comprime forme a partir de celle-ci et son utilisation comme antiseptique vaginal a action prolongee |
US6337091B1 (en) | 1997-10-27 | 2002-01-08 | Temple University - Of The Commonwealth System Of Higher Education | Matrix for controlled delivery of highly soluble pharmaceutical agents |
DE19834006A1 (de) * | 1998-07-29 | 2000-02-24 | Lohmann Therapie Syst Lts | Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen |
AU2223600A (en) * | 1999-01-06 | 2000-07-24 | Cedars-Sinai Medical Center | Hormone replacement for breast cancer patients |
HU230400B1 (hu) * | 2000-12-14 | 2016-04-28 | Ortho-Mcneil Pharmaceutical, Inc. | Szteroid hormonkészítmények és előállításukra szolgáló eljárások |
DE102005050729A1 (de) * | 2005-10-19 | 2007-04-26 | Schering Ag | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
US8828981B2 (en) | 2007-02-06 | 2014-09-09 | George Creasy | Progesterone for the treatment or prevention of spontaneous preterm birth |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4755386A (en) * | 1986-01-22 | 1988-07-05 | Schering Corporation | Buccal formulation |
US5145682A (en) * | 1986-05-30 | 1992-09-08 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration |
US5023084A (en) * | 1986-12-29 | 1991-06-11 | Rutgers, The State University Of New Jersey | Transdermal estrogen/progestin dosage unit, system and process |
JPH01168619A (ja) * | 1987-12-24 | 1989-07-04 | Takada Seiyaku Kk | 新規な酢酸クロルマジノン固形製剤 |
CA2065311C (en) * | 1989-09-08 | 2000-01-11 | Chia-Ming Chiang | Solid matrix system for transdermal drug delivery |
-
1992
- 1992-09-07 DE DE4229820A patent/DE4229820C2/de not_active Expired - Fee Related
-
1993
- 1993-09-02 EP EP93114056A patent/EP0587047B1/de not_active Expired - Lifetime
- 1993-09-02 ES ES93114056T patent/ES2169722T3/es not_active Expired - Lifetime
- 1993-09-02 DK DK93114056T patent/DK0587047T3/da active
- 1993-09-02 DE DE59310248T patent/DE59310248D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE4229820A1 (de) | 1994-03-17 |
DE59310248D1 (de) | 2002-01-24 |
EP0587047B1 (de) | 2001-12-12 |
EP0587047A3 (en) | 1997-01-15 |
DE4229820C2 (de) | 1998-12-03 |
EP0587047A2 (de) | 1994-03-16 |
ES2169722T3 (es) | 2002-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI921060A (fi) | Farmaceutiska aerosolformuleringar | |
FI922958A (fi) | Farmaceutisk sammansaettning | |
FI922252A (fi) | Farmaceutisk sammansaettning | |
FI922316A (fi) | Farmaceutisk sammansaettning | |
NO942923L (no) | Medikamenter | |
NO923127D0 (no) | Farmasoeytisk kombinasjonsformulering | |
DK0616523T3 (da) | Lægemidler | |
FI973243A0 (fi) | Uusi farmaseuttinen yhdistelmä | |
FI930882A (fi) | Farmaceutiska foereningar | |
DE69231965D1 (de) | Pharmazeutische formulierungen | |
NO920067D0 (no) | Foradditiv for droevtyggere | |
FI932655A (fi) | Imidatderivat av farmaceutiskt anvaendbara antikonvulsiva sulfamat | |
NO923859D0 (no) | Medikament | |
NO931831D0 (no) | Farmasoeytiske blandinger | |
DK0587047T3 (da) | Farmaceutisk præparat på gestagenbasis | |
DE69327153D1 (de) | Anti-hiv-medikament | |
NO934145D0 (no) | Farmas!ytiske forbindelser | |
DE4294862T1 (de) | Pharmazeutische Komposition | |
FI931251A (fi) | Farmaceutiska foereningar | |
FI952377A0 (fi) | Farmaseuttisia ibuprofeenikoostumuksia | |
DK136492D0 (da) | A pharmaceutical formulation | |
FI934317A0 (fi) | Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen | |
IS3836A (is) | Lyfjaskammtari | |
TH13625EX (th) | เอเซียโลไกลโคโปรตีน-ตัวยาคอนจูเกท | |
SE9302429D0 (sv) | New pharmaceutical preparation ii |